NCT00266708View on ClinicalTrials.gov

Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Renal Transplant Osteodystrophy
Interventions
DRUG

Risedronate

risedronate 35 mg weekly

DRUG

Placebo

Risedronate Placebo 35 mg weekly

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT00266708 - Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. | Biotech Hunter | Biotech Hunter